Journal
CELL REPORTS
Volume 2, Issue 5, Pages 1137-1142Publisher
CELL PRESS
DOI: 10.1016/j.celrep.2012.10.001
Keywords
-
Categories
Funding
- National Institutes of Health [NS40738, GM066359, NS062384, NS060115, CA092584, GM067082, AI068021, AG024827, AR051456, ES016114]
- University of Puerto Rico [2G12-RR003051]
Ask authors/readers for more resources
Oxidative damage and mitochondrial dysfunction are implicated in aging and age-related neurodegenerative diseases, including Huntington's disease (HD). Many naturally occurring antioxidants have been tested for their ability to correct for deleterious effects of reactive oxygen species, but often they lack specificity, are tissue variable, and have marginal efficacy in human clinical trials. To increase specificity and efficacy, we have designed a synthetic antioxidant, XJB-5-131, to target mitochondria. We demonstrate in a mouse model of HD that XJB-5-131 has remarkably beneficial effects. XJB-5-131 reduces oxidative damage to mitochondrial DNA, maintains mitochondrial DNA copy number, suppresses motor decline and weight loss, enhances neuronal survival, and improves mitochondrial function. The findings poise XJB-5-131 as a promising therapeutic compound.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available